Naproxen
Narcotic Use
Northwestern UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Narcotic Use cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LEVODOPA Northwestern University | Phase 2 | CCC |
carbidopa Northwestern University | Phase 2 | CCC |
Duloxetine Scripps Health | Phase 2 | CCC |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE University of Alabama at Birmingham | Early Phase 1 | CCC |
MIDAZOLAM University of Alabama at Birmingham | Early Phase 1 | CC |
View all 9 →
Same molecule, other indications
Naproxen is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →